CBD Life Sciences Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.04936 million compared to USD 0.0144 million a year ago. Net loss was USD 0.203297 million compared to USD 2.16 million a year ago.
For the six months, sales was USD 0.093553 million compared to USD 0.038749 million a year ago. Net loss was USD 0.567085 million compared to USD 3.49 million a year ago.